| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/09/2006 | CN1813771A Medicinal composition for treating skin disease and its preparing method |
| 08/09/2006 | CN1813770A Gel of triamcinolone acetonide and econazole nitrate, its preparing and quality control method |
| 08/09/2006 | CN1813761A Combined powder for injection and its preparing method |
| 08/09/2006 | CN1813760A Ceftiofur-containing powder injection for beast |
| 08/09/2006 | CN1813758A Levofloxacin hydrochloride micro-pill capsule and its preparing method |
| 08/09/2006 | CN1813756A Ganciclouir dispersible tablet and its preparing method |
| 08/09/2006 | CN1813753A Low dose entecavir formulation and use |
| 08/09/2006 | CN1813751A Voriconazole injection and its preparing method |
| 08/09/2006 | CN1813746A Intravenous administration formulation of levogatifloxacin and its preparing method |
| 08/09/2006 | CN1813744A Method for preparing levogatifloxacin formulation for intravenous injection and formulation using same |
| 08/09/2006 | CN1813737A Tetrandrine solid lipide nano particle and its preparing method |
| 08/09/2006 | CN1813724A Liranaftate paste and its preparing method |
| 08/09/2006 | CN1813722A Composition containing amoxicillin and dicloxacillin sodium |
| 08/09/2006 | CN1813713A Solution type potassium sodium dehydroandroan drographolide succinate injection and its preparing method |
| 08/09/2006 | CN1813711A Use of isoflavone compound |
| 08/09/2006 | CN1813700A Compound injection composed of probenecid and penicillin antibiotic |
| 08/09/2006 | CN1813697A Terbinafine hydrochloride vagina gel, and its preparing and quality control method |
| 08/09/2006 | CN1813691A Decanoyl acetaldehyde compound and its medicinal composition |
| 08/09/2006 | CN1813687A Method for preparing tinidazole biological composite membrane |
| 08/09/2006 | CN1813683A Azithromycin for suspension and its preparing method |
| 08/09/2006 | CN1813680A Isepamicin sulfate powder for injection and its preparing method |
| 08/09/2006 | CN1813678A Hepatitis B vaccine liposome and its trans dermal drug delivery system |
| 08/09/2006 | CN1813673A Isepamicin sulfate formulation for intravenous administration and its preparing method |
| 08/09/2006 | CN1813641A Combined complete product for nursing infant umbilical cord and its use method |
| 08/09/2006 | CN1268753C Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 08/09/2006 | CN1268748C Viral vaccine |
| 08/09/2006 | CN1268747C Recombinant newcastle disease virus RNA expression systems and vaccines |
| 08/09/2006 | CN1268745C Group B streptococcus antigens |
| 08/09/2006 | CN1268645C Therapeutic compounds comprised of anti-FC receptor binding agents |
| 08/09/2006 | CN1268643C Antibody against SARS-CoV IgY and its preparing method |
| 08/09/2006 | CN1268642C Yelk antibody specific for preventing pigling diarrhea and its preparing method and application |
| 08/09/2006 | CN1268637C I (chlamydia) protein, gene sequence and uses thereof |
| 08/09/2006 | CN1268625C Cyclic amp-specific phosphodiesterase inhibitors |
| 08/09/2006 | CN1268620C Preparing process and medicine composition of andrographolide derivatives |
| 08/09/2006 | CN1268618C 1,5-benzothiazepines compounds and its use as antilipemic agent |
| 08/09/2006 | CN1268393C Improved modified live BRSV vaccine |
| 08/09/2006 | CN1268392C Vaccine of recombined albumen for preventing and treating infection of human C type hepatitis virus and its usage |
| 08/09/2006 | CN1268378C Chinese medicinal preparation for treating skin disease |
| 08/09/2006 | CN1268368C Anti-virus houttuynia cordate medicine and its preparation |
| 08/09/2006 | CN1268362C Fungus killing agent applied in pudendal skin |
| 08/09/2006 | CN1268349C Water soluble medicament for anti inflammation, repressing bacteria, eliminating pes off smell and treating asjike, and its application |
| 08/09/2006 | CN1268345C Method of treating hepatitis delta viral infection |
| 08/09/2006 | CN1268335C Nucleoside analogs with carboxamidine wodified monocyclic base |
| 08/09/2006 | CN1268329C Use of substances that act as cascade inhibitors of the Raf/MEK/ERK signal cascade, for producing a medicament to treat DNA and RNA viruses |
| 08/09/2006 | CA2602083A1 Oxime and hydroxylamine substituted thiazolo(4,5-c) ring compounds and methods |
| 08/08/2006 | US7087778 synthesis of a 2-(2,3,4-trihalogenoanilino)propionic acid by treating trihaloaniline or trihalonitrobenzene with a metal catalyst and dehydrating agent; chemical intermediate for levofloxacin |
| 08/08/2006 | US7087759 for controlling weight; pyrrolidine or piperidine compounds |
| 08/08/2006 | US7087758 Quinoline inhibitors of hyaki and hyak3 kinases |
| 08/08/2006 | US7087661 Safe and effective biofilm inhibitory compounds and health-related uses thereof |
| 08/08/2006 | US7087649 Alcoholism; gastrointestinal disorders, Crohn's disease, antiulcer agents induced by alcoholism |
| 08/08/2006 | US7087642 Inhibitors of IMPDH enzyme |
| 08/08/2006 | US7087634 Cyclic AMP-specific phosphodiesterase inhibitors |
| 08/08/2006 | US7087629 Useful activity against Gram-positive pathogens and, in particular, against various strains exhibiting resistance to vancomycin and against E. faecium strains resistant to both aminoglycosides and clinically used beta-lactams |
| 08/08/2006 | US7087626 TGF-beta signal transduction inhibitors |
| 08/08/2006 | US7087624 Substituted pyrazole compounds |
| 08/08/2006 | US7087618 Pyrazolopyridinyl pyrimidine therapeutic compounds |
| 08/08/2006 | US7087606 Water-soluble phenylpyridazine compounds and compositions containing the same |
| 08/08/2006 | US7087603 Pyrazole compounds useful as protein kinase inhibitors |
| 08/08/2006 | US7087578 Administering activated protein c; controlling blood coagulation |
| 08/08/2006 | US7087424 In animal or plants; administering an sugar acid such as galactonic acid, gluconic acid, galacturonic acid |
| 08/08/2006 | US7087377 Method and kit for detection of tat protein with anti-tat oyi antibodies |
| 08/08/2006 | US7087253 Pharmaceutical composition, comprising eucalyptus oil and orange oil |
| 08/08/2006 | US7087249 Nanocrystalline antimicrobial metals (noble metals)formed with atomic disorder are capable of releasing highly active clusters of the antimicrobial metal sufficient to cause microbiocidal effect; anti-inflammatory activity |
| 08/08/2006 | US7087226 Lysin-deficient bacteriophages having reduced immunogenicity |
| 08/08/2006 | US7087217 Condensation aerosol for delivery of a drug selected from the group consisting of indomethacin, ketoprofen, celcoxib, rofecoxib, meclofenamic acid, fenoprofen, diflunisal, tolfenamic acid, naproxen, ibuprofen, flurbiprofen and nabumetone |
| 08/08/2006 | US7087216 Condensation aerosol for delivery of a drug selected from the group consisting of zaleplon, zolpidem and zopiclone |
| 08/08/2006 | CA2188835C Novel compounds and methods for synthesis and therapy |
| 08/03/2006 | WO2006081392A1 N-halogenated amino acids and n, n-dihalogenated amino acids in combination with hypohalous acids |
| 08/03/2006 | WO2006080564A1 RNAi THERAPEUTIC AGENT HAVING NO ADVERSE SIDE EFFECT |
| 08/03/2006 | WO2006080484A1 Cefcapene pivoxil methanesulfonate |
| 08/03/2006 | WO2006080420A1 Antigen-specific t cell inducer, antibody production inducer, immune enhancer and vaccine |
| 08/03/2006 | WO2006080340A1 Concomitant use of hepatitis c virus-origin peptide with interferon |
| 08/03/2006 | WO2006079833A1 Quinazoline derivatives as antiviral agents |
| 08/03/2006 | WO2006079791A1 Chemical compounds |
| 08/03/2006 | WO2006079656A1 Hiv inhibiting 2-( 4-cyanophenylamino) pyrimidine derivatives |
| 08/03/2006 | WO2006079291A1 Artificial synthetic single strand deoxynucleotide and vaccine composition thereof and the use |
| 08/03/2006 | WO2006079290A1 A recombinant sars-cov vaccine comprising attenuated vaccinia virus carriers |
| 08/03/2006 | WO2006079288A1 Use of human lysozyme for preparing cosmetics against acne |
| 08/03/2006 | WO2006079216A1 Liposomal compositions for parenteral delivery of agents |
| 08/03/2006 | WO2006048768A3 Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal |
| 08/03/2006 | WO2003013425A3 In vitro assays for inhibitors of hiv capsid conformational changes and for hiv capsid formation |
| 08/03/2006 | US20060173162 Bactericidak anti-apoptotic, pro-inflammatory and anti-inflammatory peptides of heparin-binding protein (hbp) |
| 08/03/2006 | US20060173078 Method of treatment or prophylaxis of symptoms of herpes viral infection |
| 08/03/2006 | US20060173076 Antibiotic/benzoyl peroxide dispenser |
| 08/03/2006 | US20060173056 Proline derivatives and use thereof as drugs |
| 08/03/2006 | US20060173040 bactericide; derivatives of pseudopeptide Andrimid in which beta-phenylalanine amide is replaced by heteroaromatic or substituted aromatic amide; N-{(1S)-3-[((1S)-1-{[(3R,4S)-1,4-Dimethyl-2,5-dioxo-3-pyrrolidinyl]carbonyl}-2-methylpropyl)amino]-3-oxo-1-phenylpropyl}-2-pyridinecarboxamide; antibiotics |
| 08/03/2006 | US20060173010 Modulators of TNF-alpha signaling |
| 08/03/2006 | US20060173003 4-Heteroarylamino-7-H(hetero)aryl-substituted, e.g., [6-(propane-2-sulfonyl)-pyridin-3-yl]-[7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-4-yl ]-amine hydrochloride; the compounds inhibit binding of vanilloid ligands to capsaicin receptors and are used to treat neuropathic pain |
| 08/03/2006 | US20060173000 5-(2-Morpholin-4-yl-ethyl)-1-(4-nitro-phenyl)-2-oxo-2,5-dihydro-1H-pyrido[3,2-b]indole-3-carbonitrile; 5-isobutyl-1-(4-nitro-phenyl)-2-oxo-2,5-dihydro-1H-pyrido[3,2-b]indole-3-carbonitrile; anti-retroviral agent |
| 08/03/2006 | US20060172997 Combinations of inhibitors of reverse transcriptase and inhibitors of virus-encoded DNA polymerase |
| 08/03/2006 | US20060172969 Citric acid, polyethylene glycol, and ofloxacin; low gelation temperatures; bioavailability |
| 08/03/2006 | US20060172955 Antibiotic/benzoyl peroxide dispenser |
| 08/03/2006 | US20060172950 Hepatitis C virus inhibitors |
| 08/03/2006 | US20060172948 Gamma-carboxyglutamate containing conopeptides |
| 08/03/2006 | US20060172946 Having serine protease inhibitory activity |
| 08/03/2006 | US20060172936 e.g. hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-3-(cyclopentyloxy)[(3-[2-(dimethylamino)ethyl]aminophenyl)sulfonyl]amino-2-hydroxypropyl)carbamate; against human immunodeficiency virus, chronic and acute viral infections |
| 08/03/2006 | US20060172348 incubating a cell or tissue sample with a purified antibody or an antigen binding fragment that binds specifically to a portion of human NAIP protein, detecting binding of antibody to such cell or tissue sample |
| 08/03/2006 | US20060172010 Process for preparing particles containing an antiviral |
| 08/03/2006 | US20060171984 Device having hydration inhibitor |
| 08/03/2006 | US20060171965 Fusion proteins of mycobacterium tuberculosis |